481 related articles for article (PubMed ID: 19476613)
21. The central and multiple roles of B cells in lupus pathogenesis.
Chan OT; Madaio MP; Shlomchik MJ
Immunol Rev; 1999 Jun; 169():107-21. PubMed ID: 10450512
[TBL] [Abstract][Full Text] [Related]
22. Regulatory IFN-γ-producing killer dendritic cells are enhanced in B6.MLR-Fas
Rodríguez-Alba JC; Girón-Pérez DA; Romero-Ramírez H; Pelayo R; Santos-Argumedo L
Eur J Immunol; 2018 Nov; 48(11):1851-1860. PubMed ID: 30289564
[TBL] [Abstract][Full Text] [Related]
23. Toll-like receptor 7 and TLR9 dictate autoantibody specificity and have opposing inflammatory and regulatory roles in a murine model of lupus.
Christensen SR; Shupe J; Nickerson K; Kashgarian M; Flavell RA; Shlomchik MJ
Immunity; 2006 Sep; 25(3):417-28. PubMed ID: 16973389
[TBL] [Abstract][Full Text] [Related]
24. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens.
Lech M; Kulkarni OP; Pfeiffer S; Savarese E; Krug A; Garlanda C; Mantovani A; Anders HJ
J Exp Med; 2008 Aug; 205(8):1879-88. PubMed ID: 18644972
[TBL] [Abstract][Full Text] [Related]
25. Abnormal thymic maturation and lymphoproliferation in MRL-Fas
Ashman RF; Singh N; Lenert PS
Lupus; 2017 Jun; 26(7):734-745. PubMed ID: 27837196
[TBL] [Abstract][Full Text] [Related]
26. Toll-like receptor 9 suppresses lupus disease in Fas-sufficient MRL Mice.
Nickerson KM; Wang Y; Bastacky S; Shlomchik MJ
PLoS One; 2017; 12(3):e0173471. PubMed ID: 28278279
[TBL] [Abstract][Full Text] [Related]
27. Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice.
Tada Y; Kondo S; Aoki S; Koarada S; Inoue H; Suematsu R; Ohta A; Mak TW; Nagasawa K
Arthritis Rheum; 2011 Mar; 63(3):738-48. PubMed ID: 21305501
[TBL] [Abstract][Full Text] [Related]
28. CD180 Ligation Inhibits TLR7- and TLR9-Mediated Activation of Macrophages and Dendritic Cells Through the Lyn-SHP-1/2 Axis in Murine Lupus.
Yang Y; Wang C; Cheng P; Zhang X; Li X; Hu Y; Xu F; Hong F; Dong G; Xiong H
Front Immunol; 2018; 9():2643. PubMed ID: 30498494
[TBL] [Abstract][Full Text] [Related]
29. Lupus-prone MRL/faslpr/lpr mice display increased AID expression and extensive DNA lesions, comprising deletions and insertions, in the immunoglobulin locus: concurrent upregulation of somatic hypermutation and class switch DNA recombination.
Zan H; Zhang J; Ardeshna S; Xu Z; Park SR; Casali P
Autoimmunity; 2009 Feb; 42(2):89-103. PubMed ID: 19156553
[TBL] [Abstract][Full Text] [Related]
30. Treatment of lupus-prone mice with a dual inhibitor of TLR7 and TLR9 leads to reduction of autoantibody production and amelioration of disease symptoms.
Barrat FJ; Meeker T; Chan JH; Guiducci C; Coffman RL
Eur J Immunol; 2007 Dec; 37(12):3582-6. PubMed ID: 18034431
[TBL] [Abstract][Full Text] [Related]
31. Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice.
Dieker J; Hilbrands L; Thielen A; Dijkman H; Berden JH; van der Vlag J
Arthritis Res Ther; 2015 Apr; 17(1):103. PubMed ID: 25886192
[TBL] [Abstract][Full Text] [Related]
32. Elevated Detection of Dual Antibody B Cells Identifies Lupus Patients With B Cell-Reactive VH4-34 Autoantibodies.
Peterson JN; Boackle SA; Taitano SH; Sang A; Lang J; Kelly M; Rahkola JT; Miranda AM; Sheridan RM; Thurman JM; Rao VK; Torres RM; Pelanda R
Front Immunol; 2022; 13():795209. PubMed ID: 35185888
[TBL] [Abstract][Full Text] [Related]
33. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
Liu L; Takeda K; Akkoyunlu M
Front Immunol; 2020; 11():1569. PubMed ID: 32849532
[TBL] [Abstract][Full Text] [Related]
34. IL-21 receptor is required for the systemic accumulation of activated B and T lymphocytes in MRL/MpJ-Fas(lpr/lpr)/J mice.
Rankin AL; Guay H; Herber D; Bertino SA; Duzanski TA; Carrier Y; Keegan S; Senices M; Stedman N; Ryan M; Bloom L; Medley Q; Collins M; Nickerson-Nutter C; Craft J; Young D; Dunussi-Joannopoulos K
J Immunol; 2012 Feb; 188(4):1656-67. PubMed ID: 22231702
[TBL] [Abstract][Full Text] [Related]
35. Characterization of reciprocal Lmb1-4 interval MRL-Faslpr and C57BL/6-Faslpr congenic mice reveals significant effects from Lmb3.
Santiago-Raber ML; Haraldsson MK; Theofilopoulos AN; Kono DH
J Immunol; 2007 Jun; 178(12):8195-202. PubMed ID: 17548658
[TBL] [Abstract][Full Text] [Related]
36. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice.
Fujii T; Okada M; Craft J
Cell Immunol; 2002; 217(1-2):23-35. PubMed ID: 12425998
[TBL] [Abstract][Full Text] [Related]
37. Ligands to nucleic acid-specific toll-like receptors and the onset of lupus nephritis.
Pawar RD; Patole PS; Ellwart A; Lech M; Segerer S; Schlondorff D; Anders HJ
J Am Soc Nephrol; 2006 Dec; 17(12):3365-73. PubMed ID: 17082246
[TBL] [Abstract][Full Text] [Related]
38. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
39. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.
Lenert P; Brummel R; Field EH; Ashman RF
J Clin Immunol; 2005 Jan; 25(1):29-40. PubMed ID: 15742155
[TBL] [Abstract][Full Text] [Related]
40. T cell-independent and toll-like receptor-dependent antigen-driven activation of autoreactive B cells.
Herlands RA; Christensen SR; Sweet RA; Hershberg U; Shlomchik MJ
Immunity; 2008 Aug; 29(2):249-60. PubMed ID: 18691914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
